Health Care·Health Care Equipment·$12.9B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.23 | N/A | +109.09% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.23 | N/A | +109.09% |
| Revenue | N/A | N/A | N/A |
Tone: Neutral
Management highlighted strong performance in EPS but did not offer detailed insights into revenue. They remain focused on growth and innovation.
Management did not provide specific revenue figures or guidance for the quarter.
The company expressed confidence in its product pipeline and market position.
Penumbra Inc reported a strong earnings per share figure, significantly beating expectations. However, the stock reacted negatively, declining by 1.45%. The lack of revenue details and guidance may have contributed to investor uncertainty.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
STRYKER CORP
May 1, 2023